Deferasirox improves liver fibrosis in beta-thalassaemia major patients. A five-year longitudinal study from a single thalassaemia centre

Br J Haematol. 2018 Apr;181(1):140-142. doi: 10.1111/bjh.14509. Epub 2017 Jan 20.
No abstract available

Keywords: chelation; liver disease; liver fibrosis; thalassaemia; transient elastography.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Deferasirox / administration & dosage*
  • Deferasirox / adverse effects
  • Female
  • Follow-Up Studies
  • Greece
  • Humans
  • Liver Cirrhosis / blood
  • Liver Cirrhosis / drug therapy*
  • Male
  • Middle Aged
  • Prospective Studies
  • beta-Thalassemia / blood
  • beta-Thalassemia / drug therapy*

Substances

  • Deferasirox